We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleImatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients.AuthorsPiazza RG; Magistroni V; Andreoni F; Franceschino A; Tornaghi L; Varella-Garcia M; Bungaro S; Colnaghi F; Corneo G; Pogliani EM; Gambacorti-Passerini CPublicationLeukemia, 2005, Vol 19, Issue 11, p1985ISSN0887-6924Publication typearticleDOI10.1038/sj.leu.2403928